Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. - Wikidata - wikimedia - TriplyDB

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

http://www.wikidata.org/entity/Q45978807

about

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs Mimicking microbial 'education' of the immune system: a strategy to revert the epidemic trend of atopy and allergic asthma?Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice Human lung cancer cells express functionally active Toll-like receptor 9 Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice Toll-like receptors: the swiss army knife of immunity and vaccine development Hib Vaccines: Past, Present, and Future Perspectives Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice Adjuvant activity of CpG oligodeoxynucleotides Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens Type I interferon is required to mount an adaptive response to immunostimulatory DNA Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.Electroporation advances in large animals.Various factors (allergen nature, mouse strain, CpG/recombinant protein expressed) influence the immune response elicited by genetic immunization.Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Strategies for improving responses to DNA vaccines CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants.Genes that induce immunity--DNA vaccines.Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.Short- and long-term changes in gene expression mediated by the activation of TLR9 Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells.Stimulation of naïve and memory T cells by cytokines.Cutting Edge: MMP-9 inhibits IL-23p19 expression in dendritic cells by targeting membrane stem cell factor affecting lung IL-17 response.DNA and RNA-based vaccines: principles, progress and prospects.A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.Vaccination against helminth parasites--the ultimate challenge for vaccinologists?Canine distemper virus DNA vaccination induces humoral and cellular immunity and protects against a lethal intracerebral challenge Deviation of the allergic IgE to an IgG response by gene immunotherapy.CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.Modular retro-vectors for transgenic and therapeutic use.

P2860

Q24644853-CFE017CE-640E-491F-8EEC-67C4C4982B02 Q24791412-3D9D516A-6256-4464-A006-3B4794BA9D78 Q24800453-C6EDC719-6258-4ED7-AF88-437B02187A54 Q24802960-3B71C71B-E737-45F4-A1B0-DD25EA57174F Q24804175-BBAAA6DC-6DA0-4040-9821-43E5CF33B5B5 Q26746644-9F77072F-D6B5-4D8B-B67E-BEB6F219EAAE Q26767144-924BC389-7155-459E-A501-3D73C2739AF8 Q27003110-D6F00921-85E3-42CE-B61D-ACAFD204B3BA Q27004381-1274CC62-323F-4C30-8A93-D6955DA11097 Q27473373-505937A4-97D3-4DEB-A17A-FB640E1050C6 Q28250104-D7C732A3-D3B0-428A-86AC-BF69D8DA6EA7 Q28347424-531BA0CD-082D-4D12-8345-775CF38E8F57 Q28508204-81EBA6E4-C5C9-4903-A3B9-C81F111FF464 Q28972540-C48BB3EB-0059-4CE8-BCD7-13DFC55CE7AB Q30382097-20930D9D-4715-4512-9286-953D1CC49C13 Q30390170-D8504A30-8257-4068-8FF4-70FF8A49E0FA Q30443793-5F76C1E2-142C-4ABA-A868-EB089B44072D Q30476834-3A0E75B2-CB9E-4A0A-B346-864A435B7635 Q30951642-13F9CF95-1E49-428F-B5B6-D81F8BB49667 Q31074458-048C4077-6DE9-4787-97DF-BD44C2ABA83B Q33509292-FA142102-EAF4-4B25-B3D4-A1F6CC305E58 Q33540135-5A0CB51D-1452-40EB-935C-06B1A9BCB196 Q33597242-337CAE55-F459-4C3A-8E9E-856BD1BF297D Q33597488-60726453-C5C9-4E16-8394-2B5E3C914EE2 Q33641393-B3C19D8D-836C-4F61-BC0C-53E64A052699 Q33683408-E284560C-F9CB-4F69-BFC4-807EE574249E Q33683729-68F7F5AE-A61C-43A9-9331-A2F7F26EECF1 Q33695664-833A6C18-90AB-403B-8B5D-B88DEA947560 Q33760871-C3EEF968-142F-4C23-BF9A-F423BA356825 Q33767857-810D893F-1C45-43E6-AAD3-9A03349DC8D8 Q33776104-252FD7DF-D6C0-4D5A-8FD7-2356D46FAC26 Q33777494-97A3B495-494B-4534-BB67-AD636A823739 Q33783789-A973921C-449C-439C-AB7F-95FF8C688DE1 Q33784968-02595731-2458-43EC-A512-0D3BCBC32408 Q33784974-9C30CF22-F919-4E1C-B6A9-5366A2727932 Q33785150-C030040E-6B26-4712-A844-ED7CC2475C5D Q33805880-DB8815FE-1900-4114-A86A-019AEF44B28A Q33843264-9BCA9D72-346A-4192-BFAD-287D4FEFE01E Q33870830-3B17DCAC-5634-403C-8023-077D69FD40A1 Q33926193-24BF9D12-715D-4C26-8352-6038ADB5E665

P2860

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

http://www.wikidata.org/entity/Q45978807

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@en

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@nl

type

label

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@en

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@nl

prefLabel

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@en

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@nl

P1433

Q45978807-009DF189-E7BF-4DFC-AD53-4B03DFAA8EEE

P1476

Q45978807-9C48DF3A-65C8-446B-B1A8-5082C6D0C2E6

P2093

Q45978807-2343281C-40DB-4A83-A8D2-9BE51765D567

Q45978807-255C8527-9496-4C8E-AFE9-8C68466243D2

Q45978807-4297E6FB-C613-4512-91AE-92717B849978

Q45978807-76D5D489-4A22-4863-A72B-0998623833BD

Q45978807-8D8CA773-7803-45C9-ADF5-D6B2734B8DEA

Q45978807-A2435F8A-4A4C-49A1-A0F7-767575D174B4

Q45978807-B657E48F-98B4-47BB-B019-9C132C57A644

Q45978807-B6F71E38-E5F0-4E7B-938D-51C1BE7412E3

Q45978807-BCAA0868-F185-4195-BFF2-F9AEA233082C

Q45978807-E15B5DE5-A152-4C2C-A678-DD0BFFFAFA3E

P2888

Q45978807-3E710D4D-6067-4639-A96E-991DD01E8102

P304

Q45978807-3549CED4-79A8-43DC-9C59-2109B4E029C4

P31

Q45978807-FF4319EF-D4F9-4BB1-B18B-6E44BD8379C1

P356

Q45978807-6FD1BE8A-F6A6-44C9-AB46-A1948A3B8136

P407

Q45978807-C0778E2B-B55B-4F39-BD7B-E177ADC0F917

P433

Q45978807-2569CBFC-4144-4C09-852F-D5FDD0C22C71

P478

Q45978807-03CCD037-70F6-4E13-BF70-455DB6A9EAF7

P577

Q45978807-003659CC-448C-4B43-B0B8-B85739AFEE2E

P5875

Q45978807-077A3D84-DE89-45DD-AF00-5247D5D8CBA7

P6179

Q45978807-0915E184-8ACF-4FEB-BC0F-8582606FE280

P698

Q45978807-4DD7F840-798D-4967-A4CF-C3D6A626ECDC

P356

P1433

Nature Medicine

P1476

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

@en

P2093

Carson DA

http://www.w3.org/2001/XMLSchema#string

Goodman JS

http://www.w3.org/2001/XMLSchema#string

Kornbluth RS

http://www.w3.org/2001/XMLSchema#string

Martin-Orozco E

http://www.w3.org/2001/XMLSchema#string

Nguyen MD

http://www.w3.org/2001/XMLSchema#string

Raz E

http://www.w3.org/2001/XMLSchema#string

Richman DD

http://www.w3.org/2001/XMLSchema#string

Roman M

http://www.w3.org/2001/XMLSchema#string

Ronaghy A

http://www.w3.org/2001/XMLSchema#string

Sato Y

http://www.w3.org/2001/XMLSchema#string

P2888

P304

849-854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM0897-849

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13964456

http://www.w3.org/2001/XMLSchema#string

P6179

1029267096

http://www.w3.org/2001/XMLSchema#string

P698

9256274

http://www.w3.org/2001/XMLSchema#string